Genmab — December 2015
-
-
DR5 IND i 2017
-
Tak Hya..Har læst den. Det bliver spændende i morgen. Jeg kommenterer i aktiesnakken under præsentationen.
-
hexa bliver næste IND efter axl!?
-
ja Hexa + DR5 kombination
-
fedt du lige kan forklare mig, hvad jeg har skrevet
-
tarmkræft er et target
-
surt for coloplas
-
haha
-
God humor dingle.
-
Duobody CD3x også IND i 2017
-
3 IND i 2018 og hele 5 IND i 2018
-
holy fuck - check lige 2019!!!
-
ja. Godt de har Dara royalty til at finansiere det
-
Så vidt jeg kan se er dette Genmabs egne stoffer. Dvs. Jannsen Duobdoy programmer etc. er udover !!!
-
axl ligner en konservativ H1 2016
-
HÅBER PÅ RR COMBO FILING I 2016!!!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind